In much of the world (but not in the U.S.,) drug-coated stents are avoided by cardiologists because of their high cost. To compensate for the inability to use these stents, many cardiologists outside of the U.S. have taken to administering sirolimus (also
Electron Beam CT, or EBCT scans (formerly called ultrafast CT scans) are useful in detecting the presence of calcium deposits in the lining of the coronary arteries. The presence of calcium deposits is a strong indicator that coronary artery disease is al
Discussion of AVD Asahi, Prowater, and Confianza guidewires in tortuous vessels and resistant coronary arterial occlusions/lesions. Success in opening chronic total occlusions is 50-75%; better guidewires are essential.
Techniques for penetrating chronic total occlusion (CTO) to ensure complete revascularization using percutaneous coronary techniques. Success is only 50–75%, even in the best hands. How to improve?
Every 3rd coronary angiography patient presents 1+ total arterial occlusion. Guidewire failure often precludes subsequent repair of the lesion in the cardiac cath lab; many of these patients are ultimately managed surgically or medically.
Major limitation of percutaneous therapy (PCI) for the treatment of chronic total occlusions (CTOs) is the inability to cross with a wire. Recanalization with Intraluminal Wire, combines guidance of wire tip and radiofrequency ablation.
=Asahi Tornus, specialty catheter by Abbott Vascular Devices =Used for crossing chronic total occlusions (CTOs) =Used with Asahi Confianza or Asahi Miracle Bros guidewires
M. Duong, A. Jung, R. Frotscher, and M. Staat. Proceedings of the VII European Congress on Computational Methods in Applied Sciences and Engineering (ECCOMAS Congress 2016), page 63--73. Athens, Institute of Structural Analysis and Antiseismic Research School of Civil Engineering National Technical University of Athens (NTUA) Greece, (2016)
M. Ungerer, M. Bohm, J. Elce, E. Erdmann, and M. Lohse. Circulation, 87 (2):
454-63(February 1993)Ungerer, M Bohm, M Elce, J S Erdmann, E Lohse, M J In Vitro Research
Support, Non-U.S. Gov't United states Circulation Circulation. 1993
Feb;87(2):454-63..
R. Jahns, V. Boivin, C. Siegmund, G. Inselmann, M. Lohse, and F. Boege. Circulation, 99 (5):
649-54(February 1999)Jahns, R Boivin, V Siegmund, C Inselmann, G Lohse, M J Boege, F Research
Support, Non-U.S. Gov't United states Circulation Circulation. 1999
Feb 9;99(5):649-54..
K. Foerster, T. Kaeferstein, F. Groner, S. Engelhardt, J. Matthes, W. Koch, M. Lohse, and S. Herzig. Naunyn Schmiedebergs Arch Pharmacol, 369 (5):
490-5(May 2004)Foerster, Katharina Kaeferstein, Tomas Groner, Ferdi Engelhardt,
Stefan Matthes, Jan Koch, Walter J Lohse, Martin J Herzig, Stefan
Research Support, Non-U.S. Gov't Germany Naunyn-Schmiedeberg's archives
of pharmacology Naunyn Schmiedebergs Arch Pharmacol. 2004 May;369(5):490-5.
Epub 2004 Apr 9..